AGR3 in Breast Cancer : Prognostic Impact and Suitable Serum-Based Biomarker for Early Cancer Detection
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: 10.1371/journal.pone.0122106
- Ereignis
-
Veröffentlichung
- (wo)
-
Aachen
- (wer)
-
Universitätsbibliothek der RWTH Aachen
- (wann)
-
2015
- Urheber
-
Garczyk, Stefan
Stillfried, Saskia von
Antonopoulos, Wiebke
Hartmann, Arndt
Schrauder, Michael G.
Fasching, Peter A.
Anzeneder, Tobias
Tannapfel, Andrea
Ergönenc, Yavuz
Knüchel, Ruth
Rose, Michael
Dahl, Edgar
- DOI
-
10.18154/RWTH-2015-02749
- URN
-
urn:nbn:de:101:1-2018110506012835524678
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:49 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Garczyk, Stefan
- Stillfried, Saskia von
- Antonopoulos, Wiebke
- Hartmann, Arndt
- Schrauder, Michael G.
- Fasching, Peter A.
- Anzeneder, Tobias
- Tannapfel, Andrea
- Ergönenc, Yavuz
- Knüchel, Ruth
- Rose, Michael
- Dahl, Edgar
- Universitätsbibliothek der RWTH Aachen
Entstanden
- 2015
Ähnliche Objekte (12)
AGR3 in Breast Cancer: Prognostic Impact and Suitable Serum-Based Biomarker for Early Cancer Detection
Invasive Breast Cancer: Recognition of Molecular Subtypes
Endocrine Treatment for Breast Cancer Patients Revisited—History, Standard of Care, and Possibilities of Improvement
CDK4/6 Inhibitors—Overcoming Endocrine Resistance Is the Standard in Patients with Hormone Receptor-Positive Breast Cancer
P53 regulated microRNAs in colorectal cancer
Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients
Mammographic texture as new and independent breast cancer risk factor
Promoting-Activity-Test : mitogene Wirkung von Xenobiotika als Indikator ihrer tumorigenen Potenz in einem In-vivo-Kurzzeittestsystem
Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screening
The role and prognostic relevance of CD68+ macrophages and DNMT3B in colon carcinomas
Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer
The Ability of Radiomics from PET/CT in Predicting the Status of PD-L1 Expression and KRAS Mutation in Non-Small Cell Lung Cancer
AGR3 in Breast Cancer: Prognostic Impact and Suitable Serum-Based Biomarker for Early Cancer Detection
Invasive Breast Cancer: Recognition of Molecular Subtypes
Endocrine Treatment for Breast Cancer Patients Revisited—History, Standard of Care, and Possibilities of Improvement
CDK4/6 Inhibitors—Overcoming Endocrine Resistance Is the Standard in Patients with Hormone Receptor-Positive Breast Cancer
P53 regulated microRNAs in colorectal cancer
Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients
Mammographic texture as new and independent breast cancer risk factor
Promoting-Activity-Test : mitogene Wirkung von Xenobiotika als Indikator ihrer tumorigenen Potenz in einem In-vivo-Kurzzeittestsystem
Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screening
The role and prognostic relevance of CD68+ macrophages and DNMT3B in colon carcinomas
Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer
The Ability of Radiomics from PET/CT in Predicting the Status of PD-L1 Expression and KRAS Mutation in Non-Small Cell Lung Cancer
AGR3 in Breast Cancer: Prognostic Impact and Suitable Serum-Based Biomarker for Early Cancer Detection
Invasive Breast Cancer: Recognition of Molecular Subtypes
Endocrine Treatment for Breast Cancer Patients Revisited—History, Standard of Care, and Possibilities of Improvement
CDK4/6 Inhibitors—Overcoming Endocrine Resistance Is the Standard in Patients with Hormone Receptor-Positive Breast Cancer
P53 regulated microRNAs in colorectal cancer
Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients
Mammographic texture as new and independent breast cancer risk factor
Promoting-Activity-Test : mitogene Wirkung von Xenobiotika als Indikator ihrer tumorigenen Potenz in einem In-vivo-Kurzzeittestsystem
Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screening
The role and prognostic relevance of CD68+ macrophages and DNMT3B in colon carcinomas
Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer